Eli Lilly & Company (NYSE: LLY)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $1257.03
-
Support level$1252.46
-
Resistance levelN/A
-
Beta0.5
-
RSI (14-day)65.9
- LLY is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- LLY is one of this month's top performers with a return of 9.0 percent, beating 90 percent of stocks in the S&P-100.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $799.57 | $1280.34 | 96.1% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $1079.91 | $1180.35 | $1178.76 | $1190.47 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week8.8%
-
In the next month18.3%
-
In the next year66.9%
| Period | Value |
|---|---|
| Historical (5 year) | 32.4% |
| Last month | 29.4% |
| Current estimate | 32.5% |
| Next month forecast | 32.3% |